Medicinova Announces Acceptance of Abstract Regarding Mn-166 (Ibudilast) in Combat-ALS Clinical Trial for Presentation at the 2024 Annual Neals (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting
美第奇新星生物技術宣佈接受有關Mn-166(伊布地拉斯特)在Combat-ALS臨床試驗中的摘要,將在2024年Neals(東北肌萎縮性側索硬化聯盟)年會上進行報告。